Matthew Sansone
9Patents
2h-index
7Co-inventors
40Inventor score
Filing activity: Mar 4, 2008 → Mar 25, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9107816B2 | Implantable device for controlled dissolution and diffusion of low solubility drug | Human Necessities | 39 | Active |
| US8367656B2 | Polymorphs of 7-[(3-chloro-6,11-dihydro-6-methyldibenzo[c,f][1,2]thiazepin-11-yl)amino]heptanoic acid S,S dioxide and methods of making and using the same | Human Necessities | 10 | Active |
| US10137287B2 | Drug delivery devices and methods for controlled drug release through device orifice | Human Necessities | 2 | Active |
| US10315019B2 | Drug delivery devices with drug-permeable component and methods | Human Necessities | 1 | Active |
| US10729823B2 | Multi-unit drug delivery devices and methods | Human Necessities | 1 | Active |
| US10286199B2 | Drug delivery devices with drug-permeable component and methods | Human Necessities | 0 | Active |
| US11285304B2 | Drug delivery devices with drug-permeable component and methods | Human Necessities | 0 | Active |
| US12409304B2 | Drug delivery devices with drug-permeable component and methods | Human Necessities | 0 | Active |
| US8754093B2 | Co-crystal of etravirine and nicotinamide | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.